Daptomycin: a new treatment for insidious infections due to gram-positive pathogens.
作者： Philippe Cottagnoud
DOI:
关键词:
摘要: Daptomycin, a new lipopeptide antibiotic, is highly bactericidal against the majority of Gram-positive human pathogens, including methicillin-resistant (MRSA) and vancomycin-resistant enterococci. Its mechanism action unique resulting in destruction membrane potential without lysing cell wall. The daptomycin, its antibacterial spectrum, development resistance pre- clinical studies are discussed this review.
smw.ch参考文章(60)
G M Eliopoulos, S Willey, E Reiszner, P G Spitzer, G Caputo, R C Moellering, In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy. ,vol. 30, pp. 532- 535 ,(1986) , 10.1128/AAC.30.4.532
Nasia Safdar, David Andes, W. A. Craig, In Vivo Pharmacodynamic Activity of Daptomycin Antimicrobial Agents and Chemotherapy. ,vol. 48, pp. 63- 68 ,(2004) , 10.1128/AAC.48.1.63-68.2004
Michael R Jacobs, Streptococcus pneumoniae: epidemiology and patterns of resistance. The American Journal of Medicine. ,vol. 117, pp. 3- 15 ,(2004) , 10.1016/J.AMJMED.2004.07.003
Robert E.W. Hancock, Annett Rozek, Role of membranes in the activities of antimicrobial cationic peptides Fems Microbiology Letters. ,vol. 206, pp. 143- 149 ,(2002) , 10.1111/J.1574-6968.2002.TB11000.X
F. T. COUNTER, N. E. ALLEN, D. S. FUKUDA, J. N. HOBBS, J. OTT, P. W. ENSMINGER, J. S. MYNDERSE, D. A. PRESTON, C. Y. E. WU, A54145 a new lipopeptide antibiotic complex: microbiological evaluation. The Journal of Antibiotics. ,vol. 43, pp. 616- 622 ,(1990) , 10.7164/ANTIBIOTICS.43.616
Vance G. Fowler, Helen W. Boucher, G. Ralph Corey, Elias Abrutyn, Adolf W. Karchmer, Mark E. Rupp, Donald P. Levine, Henry F. Chambers, Francis P. Tally, Gloria A. Vigliani, Christopher H. Cabell, Arthur Stanley Link, Ignace DeMeyer, Scott G. Filler, Marcus Zervos, Paul Cook, Jeffrey Parsonnet, Jack M. Bernstein, Connie Savor Price, Graeme N. Forrest, Gerd Fätkenheuer, Marcelo Gareca, Susan J. Rehm, Hans Reinhardt Brodt, Alan Tice, Sara E. Cosgrove, Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus The New England Journal of Medicine. ,vol. 355, pp. 653- 665 ,(2006) , 10.1056/NEJMOA053783
B L Lee, M Sachdeva, H F Chambers, Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrobial Agents and Chemotherapy. ,vol. 35, pp. 2505- 2508 ,(1991) , 10.1128/AAC.35.12.2505
R. Wise, T. Gee, J. M. Andrews, B. Dvorchik, G. Marshall, Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers Antimicrobial Agents and Chemotherapy. ,vol. 46, pp. 31- 33 ,(2002) , 10.1128/AAC.46.1.31-33.2002
G M Eliopoulos, C Thauvin, B Gerson, R C Moellering, In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy. ,vol. 27, pp. 357- 362 ,(1985) , 10.1128/AAC.27.3.357
J. B. Patel, L. A. Jevitt, J. Hageman, L. C. McDonald, F. C. Tenover, An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clinical Infectious Diseases. ,vol. 42, pp. 1652- 1653 ,(2006) , 10.1086/504084